Exelixix, Inc. (NASDAQ:EXEL) has announced two upcoming events for December 1st and 2nd. The company will speak at the Piper Jaffray 21st Annual Healthcare Conference on Tuesday, December 1, at 1:30 pm ET. The presentation will be available online at http://ir.exelixis.com, on the Event Calendar page. The following day, Wednesday, December 2, the company has scheduled its Fifth Annual R&D Day at 2:00 pm EST. The company’s management will discuss company development, corporate strategy, and financial outlook at that time. R&D day will be webcasted on the Investor Relations site and archived until 12:00 am EST January 2, 2010. To listen to the presentation by phone, dial 866.730.5767, or 857.350.1591 for international callers. The replay pass code is 69576914.
Penny Stock Professor, a leading financial publication, is pleased to alert investors of stocks on the move. Sign Up for our Free Penny Stock Picks.
Exelixis, Inc. (Exelixis) is developing therapies for cancer and other serious diseases. Through its drug discovery and development activities, the Company is building a portfolio of novel compounds. Exelixis has a pipeline of compounds in various stages of development that will potentially treat cancer, renal disease and various metabolic and cardiovascular disorders. Its most advanced pharmaceutical programs focus on drug discovery and development of small molecule drugs for cancer. The Company has nine compounds in clinical development: XL184, XL147, XL765, XL518, XL228, XL019, XL139, XL413 and XL888. Exelixis also has out-licensed to third parties for further development and commercialization of five compounds in preclinical and clinical development: XL880, XL281, XL652, XL550 and FXR Program. The Company has established commercial collaborations with several pharmaceutical and biotechnology companies, including Bristol-Myers Squibb Company, Genentech, Inc. and GlaxoSmithKline.
Follow us on Twitter: http://www.twitter.com/pennystockspro
Sign up for the free Penny Stock Professor newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.
About Us
Penny Stock Professor is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer.
